Join the club for FREE to access the whole archive and other member benefits.

OncoSenX

Late stage pre-clinical cancer company targeting solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.

The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.

Visit website: https://www.oncosenx.com/

 oncosenx

See also: Company Oisin Biotechnologies - Drug development company focused on the senolytic technology to fight age-related diseases

Details last updated 06-Nov-2019

OncoSenX News

OncoSenX raises more funds for cancer therapy, plans for clinical trial

OncoSenX raises more funds for cancer therapy, plans for clinical trial

GeekWire - 11-May-2020

Allowing developments on tech that will kill cancer based on their genetics

Fight Aging! reports back from SENS Research Foundation Pitch Day

Fight Aging! reports back from SENS Research Foundation Pitch Day

Fight Aging! - 20-Jan-2020

When some of these succeed in human trials even more money will pile in to fund further advances

OncoSenX targets solid tumours with senolytics

OncoSenX targets solid tumours with senolytics

Lifespan.io (LEAF) - 22-Oct-2019

Phase 1 clinical trial starting early 2020